Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 33.00
+0.20 (0.61%)
Jul 30, 2026, 9:35 AM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.24 billion as of July 29, 2026. Its market cap has decreased by -17.94% in one year.
Market Cap
4.24B
Enterprise Value
3.48B
Revenue
69.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.00
ChartMarket Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 4.24B, a decrease of -12.78%. That is a compound annual growth rate of -3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 4.46B | -33.38% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.52B |
| TWi Biotechnology | 5.51B |
| Steminent Biotherapeutics | 5.17B |
| Mycenax Biotech | 5.17B |
| UnicoCell Biomed | 4.94B |
| Medigen Biotechnology | 4.60B |
| Sinew Pharma | 4.32B |
| Genovate Biotechnology | 3.65B |